Bristol Myers Squibb (BMY) |
United States |
$149.383B |
10.65 |
Amgen (AMGN) |
United States |
$140.687B |
14.71 |
CSL (CSLLY) |
Australia |
$96.127B |
0.00 |
Gilead Sciences (GILD) |
United States |
$78.220B |
10.40 |
Vertex Pharmaceuticals (VRTX) |
United States |
$58.800B |
27.34 |
Regeneron Pharmaceuticals (REGN) |
United States |
$55.264B |
19.60 |
Illumina (ILMN) |
United States |
$54.172B |
74.51 |
Moderna (MRNA) |
United States |
$51.332B |
0.00 |
Biogen (BIIB) |
United States |
$43.131B |
7.66 |
Alexion Pharmaceuticals (ALXN) |
United States |
$34.282B |
13.66 |
Seagen (SGEN) |
United States |
$31.812B |
83.74 |
BeiGene (BGNE) |
Cayman Islands |
$30.549B |
0.00 |
Genmab (GMAB) |
Denmark |
$28.919B |
34.20 |
Genmab (GNMSF) |
Denmark |
$27.046B |
6.23 |
BioNTech SE (BNTX) |
Germany |
$23.950B |
0.00 |
Exact Sciences (EXAS) |
United States |
$22.156B |
0.00 |
Incyte (INCY) |
United States |
$20.156B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$19.178B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$18.067B |
68.51 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$17.844B |
0.00 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$17.416B |
24.89 |
Guardant Health (GH) |
United States |
$15.723B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$14.956B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.769B |
98.02 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$13.358B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$13.019B |
83.26 |
QIAGEN (QGEN) |
Netherlands |
$12.114B |
27.28 |
Repligen (RGEN) |
United States |
$11.168B |
158.40 |
Mirati Therapeutics (MRTX) |
United States |
$10.748B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$10.242B |
0.00 |
Twist Bioscience (TWST) |
United States |
$9.209B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$8.979B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$8.873B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$8.658B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$8.654B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$8.538B |
0.00 |
Novavax (NVAX) |
United States |
$8.275B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$7.650B |
0.00 |
Exelixis (EXEL) |
United States |
$7.378B |
49.54 |
Sarepta Therapeutics (SRPT) |
United States |
$7.094B |
0.00 |
Galapagos (GLPG) |
Belgium |
$6.654B |
0.00 |
Beam Therapeutics (BEAM) |
United States |
$6.453B |
0.00 |
Halozyme Therapeutics (HALO) |
United States |
$6.360B |
294.06 |
Amicus Therapeutics (FOLD) |
United States |
$6.069B |
0.00 |
SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.964B |
17.44 |
NeoGenomics (NEO) |
United States |
$5.938B |
1782.67 |
Blueprint Medicines (BPMC) |
United States |
$5.713B |
18.91 |
Emergent Biosolutions (EBS) |
United States |
$5.617B |
18.43 |
Certara (CERT) |
United States |
$5.252B |
0.00 |
Eidos Therapeutics (EIDX) |
United States |
$4.994B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$4.921B |
0.00 |
Editas Medicine (EDIT) |
United States |
$4.732B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$4.686B |
0.00 |
Vir Biotechnology (VIR) |
United States |
$4.648B |
0.00 |
China Biologic Products (CBPO) |
China |
$4.647B |
30.12 |
Arvinas (ARVN) |
United States |
$4.247B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$4.094B |
0.00 |
Legend Biotech (LEGN) |
United States |
$3.813B |
0.00 |
Insmed (INSM) |
United States |
$3.807B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$3.761B |
136.14 |
Alkermes (ALKS) |
Ireland |
$3.501B |
34.38 |
Bluebird Bio (BLUE) |
United States |
$3.441B |
0.00 |
Global Blood Therapeutics (GBT) |
United States |
$3.076B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$2.913B |
0.00 |
I-Mab (IMAB) |
China |
$2.839B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$2.737B |
0.00 |
Zymeworks (ZYME) |
Canada |
$2.540B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$2.521B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$2.437B |
0.00 |
Amarin (AMRN) |
Ireland |
$2.397B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$2.290B |
0.00 |
ADC Therapeutics SA (ADCT) |
Switzerland |
$2.273B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$2.101B |
0.00 |
Viela Bio (VIE) |
United States |
$2.010B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$1.978B |
16.38 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.966B |
50.95 |
Scholar Rock Holding (SRRK) |
United States |
$1.953B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$1.940B |
0.00 |
NantKwest (NK) |
United States |
$1.932B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$1.919B |
0.00 |
Genetron Holdings (GTH) |
China |
$1.878B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.869B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.827B |
0.00 |
NGM Biopharmaceuticals (NGM) |
United States |
$1.787B |
0.00 |
Vericel (VCEL) |
United States |
$1.750B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$1.746B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.694B |
0.00 |
Precigen (PGEN) |
United States |
$1.597B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$1.587B |
0.00 |
Heska (HSKA) |
United States |
$1.529B |
0.00 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.525B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$1.524B |
0.00 |
Codexis (CDXS) |
United States |
$1.521B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.496B |
0.00 |
Forma Therapeutics Holdings (FMTX) |
United States |
$1.488B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$1.487B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$1.422B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$1.401B |
0.00 |
Cellectis S.A (CLLS) |
France |
$1.315B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.296B |
8.57 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.287B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$1.254B |
0.00 |
Frequency Therapeutics (FREQ) |
United States |
$1.240B |
0.00 |
Alector (ALEC) |
United States |
$1.231B |
0.00 |
Epizyme (EPZM) |
United States |
$1.215B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$1.165B |
0.00 |
Mesoblast (MESO) |
Australia |
$1.155B |
0.00 |
Athenex (ATNX) |
United States |
$1.088B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$1.083B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$1.065B |
0.00 |
MiMedx (MDXG) |
United States |
$1.014B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$1.001B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.992B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.976B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.973B |
0.00 |
Morphic Holding (MORF) |
United States |
$0.970B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$0.965B |
0.00 |
Compugen (CGEN) |
Israel |
$0.924B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$0.918B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.914B |
24.33 |
Cara Therapeutics (CARA) |
United States |
$0.899B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.874B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.811B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$0.806B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.794B |
0.00 |
MannKind (MNKD) |
United States |
$0.786B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.779B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.777B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.765B |
38.83 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.752B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.711B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.711B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.701B |
0.00 |
Curis (CRIS) |
United States |
$0.693B |
0.00 |
Cardiff Oncology (CRDF) |
United States |
$0.691B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$0.682B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.666B |
0.00 |
Agenus (AGEN) |
United States |
$0.650B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.639B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.631B |
0.00 |
Affimed (AFMD) |
Germany |
$0.621B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.607B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.583B |
78.85 |
Prothena (PRTA) |
Ireland |
$0.575B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.566B |
0.00 |
Aquinox Pharmaceuticals (NLTX) |
United States |
$0.556B |
0.00 |
Pandion Therapeutics (PAND) |
United States |
$0.555B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.545B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.545B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.536B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.526B |
0.00 |
Geron (GERN) |
United States |
$0.526B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.511B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.508B |
0.00 |
FORTE BIOSCIENC (FBRX) |
United States |
$0.487B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.467B |
0.00 |
Amryt Pharma (AMYT) |
United Kingdom |
$0.465B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.460B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.452B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.451B |
0.00 |
XOMA (XOMA) |
United States |
$0.441B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.440B |
20.71 |
AC Immune SA (ACIU) |
Switzerland |
$0.439B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.438B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.437B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.421B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.411B |
0.00 |
Verastem (VSTM) |
United States |
$0.411B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.399B |
0.00 |
Athersys (ATHX) |
United States |
$0.397B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.397B |
10.09 |
AMMO (POWW) |
United States |
$0.396B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.394B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.385B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.363B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.363B |
0.00 |
NextCure (NXTC) |
United States |
$0.360B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.348B |
0.00 |
Trevena (TRVN) |
United States |
$0.342B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.342B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.335B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.334B |
8.58 |
Lineage Cell Therapeutics (LCTX) |
United States |
$0.325B |
0.00 |
Kamada (KMDA) |
Israel |
$0.322B |
15.06 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.308B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.288B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.286B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
IBio (IBIO) |
United States |
$0.280B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.271B |
0.00 |
Aptinyx (APTX) |
United States |
$0.241B |
0.00 |
HOOKIPA Pharma (HOOK) |
United States |
$0.240B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.237B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$0.231B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.229B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.225B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.221B |
0.00 |
Exicure (XCUR) |
United States |
$0.219B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.209B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.209B |
0.00 |
Cerecor (CERC) |
United States |
$0.206B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.203B |
0.00 |
TELA Bio (TELA) |
United States |
$0.202B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.201B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.200B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.200B |
0.00 |
VolitionRX (VNRX) |
United States |
$0.199B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.198B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.197B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.196B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.195B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.184B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.184B |
0.00 |
Nicox SA (NICXF) |
France |
$0.182B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.177B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.159B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.157B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.156B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.156B |
0.00 |
Dyadic (DYAI) |
United States |
$0.153B |
0.00 |
Evogene (EVGN) |
Israel |
$0.153B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.153B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.153B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.148B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.147B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.143B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.137B |
0.00 |
Protalix BioTherapeutics (PLX) |
Israel |
$0.132B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.130B |
0.00 |
AIT Therapeutics (XAIR) |
United States |
$0.126B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.125B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.124B |
256.00 |
Ecology Coatings (ABVC) |
United States |
$0.122B |
0.00 |
Prometic Life Sciences (LMNL) |
Canada |
$0.120B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.119B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.118B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.116B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.114B |
0.00 |
Synlogic (SYBX) |
United States |
$0.114B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.105B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.105B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.105B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.101B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.099B |
0.00 |
MiRagen Therapeutics (MGEN) |
United States |
$0.097B |
0.00 |
Novogen (KZIA) |
Australia |
$0.097B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.097B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.092B |
0.00 |
CytRx (CYTR) |
United States |
$0.088B |
0.00 |
CollPlant Holdings (CLGN) |
Israel |
$0.082B |
0.00 |
Stealth BioTherapeutics (MITO) |
United States |
$0.079B |
37.75 |
Seelos Therapeutics (SEEL) |
United States |
$0.077B |
0.00 |
Adocia (ADOCY) |
France |
$0.074B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.070B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.068B |
0.00 |
AnPac Bio-Medical Science (ANPC) |
China |
$0.064B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.061B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.060B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.060B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.057B |
0.00 |
Yumanity Therapeutics (YMTX) |
United States |
$0.057B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.057B |
0.00 |
Appili Therapeutics (APLIF) |
Canada |
$0.055B |
0.00 |
Happiness Biotech Group (HAPP) |
China |
$0.054B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.052B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.051B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.051B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.049B |
0.00 |
BioCardia (BCDA) |
United States |
$0.047B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.044B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.044B |
0.00 |
Soligenix (SNGX) |
United States |
$0.043B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.043B |
0.00 |
Chanticleer Holdings (SONN) |
United States |
$0.043B |
0.00 |
Advaxis (ADXS) |
United States |
$0.042B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.042B |
0.00 |
Spherix (AIKI) |
United States |
$0.041B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.040B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.039B |
0.00 |
Celsion (CLSN) |
United States |
$0.034B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.030B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.028B |
0.00 |
Neuralstem (SNCA) |
United States |
$0.024B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
Cesca Therapeutics (THMO) |
United States |
$0.019B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.017B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.015B |
0.00 |
BioPharmX (TMBR) |
United States |
$0.013B |
0.00 |
CTD Holdings (CYTH) |
United States |
$0.009B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.008B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.004B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.000B |
0.00 |
Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |